Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LAK Cells and Rituximab Maintenance in Follicular Lymphoma
NCT01329354Phase 2Unknown
- Sponsor
- Universidad de Navarra
- Start
- Mar 2011
- Primary completion
- Nov 2019
- Countries
- 1
01
Overview
A Phase 2 trial of lymphokine-activated killer cells in follicular lymphoma (FL), sponsored by Universidad de Navarra. Status: unknown.
02
Drugs
lymphokine-activated killer cells
03
Conditions
follicular lymphoma (FL)
Beyond the preview
Go deeper on NCT01329354.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01329354.